MARKET EYE-Pharma stocks fall on speculation over pricing policy

Thu Nov 22, 2012 2:47pm IST

Related Topics

Stocks

   

* Shares in Indian drugmakers fall on speculation the
government's final decision on the pricing policy for the sector
might be more disruptive than expected.
* Local media reports suggest a panel of ministers has agreed to
settle on a market-based pricing mechanism, as expected, but
capping drug prices at a simple average price of brands as
opposed to the initial proposal of using a weighted average. link.reuters.com/jur24t
* The proposal, if finalised, would be "incrementally negative"
for the sector, but the impact would vary from company to
company, Nomura says in a note on Thursday.
* The new proposal is likely to be more negative for Dr Reddy's
, Glenmark and Cadila Healthcare,
Nomura says. 
* Cipla falls 0.1 percent, while Ranbaxy Laboratories
 is down 0.9 percent. 
* Dr Reddy's Laboratories is flat, Glenmark Pharmaceuticals is
up 3.9 percent and Cadila gains 2.2 percent.

 (abhishek.vishnoi@thomsonreuters.com /;
abhishek.vishnoi.reuters.com@reuters.net/kaustubh.kulkarni@thoms
onreuters.com /; kaustubh.kulkarni.reuters.com@reuters.net)
FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Iron Ore Mining

REUTERS SHOWCASE

Telecom Sector

Telecom Sector

RIL telecoms unit in tower lease pact with ATC  Full Article 

Japanese Economy

Japanese Economy

Japan exports growth slows sharply, keeps pressure on BOJ to act  Full Article 

A Tough Sell

A Tough Sell

Insurance against a China financial crisis  Full Article 

Tyre Debris

Tyre Debris

Bangalore-bound Malaysia Airlines plane turns back after tyre burst on takeoff  Full Article 

Digital Currency

Digital Currency

At Mt. Gox bitcoin hub, 'geek' CEO sought both control and escape  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage